Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI
出版年份 2014 全文链接
标题
Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI
作者
关键词
Relaxation times, Bevacizumab, Tumor progression, Quantitative MRI
出版物
NEURORADIOLOGY
Volume 57, Issue 1, Pages 11-20
出版商
Springer Nature
发表日期
2014-10-06
DOI
10.1007/s00234-014-1445-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis
- (2013) Alina Jurcoane et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Response Assessment in Neuro-Oncology Criteria: Implementation Challenges in Multicenter Neuro-Oncology Trials
- (2011) W.B. Pope et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
- (2011) L.C. Hygino da Cruz et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab
- (2011) Benjamin M. Ellingson et al. JOURNAL OF NEURO-ONCOLOGY
- FSL
- (2011) Mark Jenkinson et al. NEUROIMAGE
- Signal intensity in T2’ magnetic resonance imaging is related to brain glioma grade
- (2010) Laura Saitta et al. EUROPEAN RADIOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffusely Abnormal White Matter in Chronic Multiple Sclerosis
- (2009) Alexandra Seewann et al. ARCHIVES OF NEUROLOGY
- Pseudoprogression and pseudoresponse in the treatment of gliomas
- (2009) Dieta Brandsma et al. CURRENT OPINION IN NEUROLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients
- (2009) Johannes Rieger et al. JOURNAL OF NEURO-ONCOLOGY
- A fast B1-mapping method for the correction and normalization of magnetization transfer ratio maps at 3 T
- (2009) Steffen Volz et al. NEUROIMAGE
- Just Enough Palliation: Radiation Dose and Outcome in Patients With Non–Small-Cell Lung Cancer
- (2008) Henry Wagner JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More